title: Treatment of Severe Hypercholesterolemia in a Woman With Advanced Primary Sclerosing Cholangitis.
authors.affiliation: Department of Medicine, University of Toronto, Toronto, ON, Canada2Department of Physiology, University of Toronto, Toronto, ON, Canada3Banting and Best Diabetes Centre, University of Toronto, Toronto, ON, Canada.
authors.forename: Changting
authors.initials: C
authors.lastname: Xiao
authors.affiliation: Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Hegele
authors.affiliation: Department of Medicine, University of Toronto, Toronto, ON, Canada2Department of Physiology, University of Toronto, Toronto, ON, Canada3Banting and Best Diabetes Centre, University of Toronto, Toronto, ON, Canada.
authors.forename: Gary F
authors.initials: GF
authors.lastname: Lewis
mesh_terms: D000328:Adult; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D015209:Cholangitis, Sclerosing / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003084:Colestipol / Q000627:therapeutic use*; D005148:Facial Dermatoses / Q000209:etiology; D005260:Female; D006229:Hand Dermatoses / Q000209:etiology; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008073:Lipoprotein-X / Q000097:blood*; D010951:Plasma Exchange; D012720:Severity of Illness Index; D012871:Skin Diseases / Q000209:etiology; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*; D014973:Xanthomatosis / Q000209:etiology
chemical_list: D002756:Cholagogues and Choleretics; D000960:Hypolipidemic Agents; D008073:Lipoprotein-X; D014580:Ursodeoxycholic Acid; D003084:Colestipol